Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of plasma exchange with 5% human albumin in mild to moderate Alzheimer's disease
2007-000414-36Phase 2Completed
- Sponsor
- Grifols
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of albumin (human) in Alzheimer's disease (AD), sponsored by Grifols. Primary endpoint: Change in cerebrospinal fluid AB1-42 levels. Started Apr 2007; status: completed.
02
Drugs
albumin (human)
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2007-000414-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000414-36.